These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8473016)

  • 1. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
    Kroegel C; Matthys H
    Immunology; 1993 Feb; 78(2):279-85. PubMed ID: 8473016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA; Kroegel C; Barnes PJ
    J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of degranulation from human eosinophils by platelet-activating factor.
    Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
    J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo.
    Kunievsky B; Yavin E
    J Pharmacol Exp Ther; 1992 Nov; 263(2):562-8. PubMed ID: 1432689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells.
    Pang L; Knox AJ
    Br J Pharmacol; 1997 Jun; 121(3):579-87. PubMed ID: 9179403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N; Agrawal DK; Townley RG
    J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils.
    Dent G; Muñoz NM; Rühlmann E; Zhu X; Leff AR; Magnussen H; Rabe KF
    Am J Respir Cell Mol Biol; 1998 Jan; 18(1):136-44. PubMed ID: 9448055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids.
    Schleimer RP; Davidson DA; Lichtenstein LM; Adkinson NF
    J Immunol; 1986 Apr; 136(8):3006-11. PubMed ID: 3082976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
    Holgate ST; Burns GB; Robinson C; Church MK
    J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
    Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
    Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
    J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.
    Yukawa T; Kroegel C; Evans P; Fukuda T; Chung KF; Barnes PJ
    Immunology; 1989 Sep; 68(1):140-3. PubMed ID: 2807369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
    Filep JG; Braquet P; Mózes T
    Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction.
    Weisman SM; Felsen D; Vaughan ED
    J Pharmacol Exp Ther; 1985 Oct; 235(1):10-5. PubMed ID: 3862805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.
    Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S
    Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of platelet activating factor on release of thromboxane B2 from human granulocytes and platelets].
    Imai T; Horikoshi S; Kurokawa M; Idaira K; Mita S; Adachi M; Okamoto M
    Arerugi; 1994 Jul; 43(7):809-14. PubMed ID: 7980021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors.
    Hubbard WC; Alley MC; Gray GN; Green KC; McLemore TL; Boyd MR
    Cancer Res; 1989 Feb; 49(4):826-32. PubMed ID: 2536293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils.
    Cromwell O; Wardlaw AJ; Champion A; Moqbel R; Osei D; Kay AB
    J Immunol; 1990 Dec; 145(11):3862-8. PubMed ID: 2246516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.